- Filed
- May 13, 2025 12:00 AM ET
- Period of report
- —
Restated figures. One or more values in this filing restate previously reported amounts.
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Shares Outstanding | Q1 2025 · May 9, 2025 | 34.14M sh |
| Short Term Debt | Q1 2025 · Mar 31, 2025 | $523K |
| Short Term Debt | Q1 2025 · Dec 31, 2024 | $818K |
| Cash And Equivalents | Q1 2025 · Mar 31, 2025 | $10.09M |
| Cash And Equivalents | Q1 2025 · Dec 31, 2024 | $1.35M |
| Current Liabilities | Q1 2025 · Mar 31, 2025 | $2.92M |
| Current Liabilities | Q1 2025 · Dec 31, 2024 | $4.87M |
| Total Liabilities | Q1 2025 · Mar 31, 2025 | $3.88M |
| Total Liabilities | Q1 2025 · Dec 31, 2024 | $4.87M |
| Current Assets | Q1 2025 · Mar 31, 2025 | $11.89M |
| Current Assets | Q1 2025 · Dec 31, 2024 | $2.91M |
| Total Assets | Q1 2025 · Mar 31, 2025 | $13.38M |
| Total Assets | Q1 2025 · Dec 31, 2024 | $3.8M |
| Shares Diluted | Q1 2025 · Mar 31, 2024 | 5.96M sh |
| Capex | Q1 2025 · Mar 31, 2024 | $1K |
| Operating Cash Flow | Q1 2025 · Mar 31, 2024 | −$5.07M |
| Stockholders Equity | Q1 2025 · Mar 31, 2024 | $7.16M |
| Stockholders Equity | Q1 2025 · Dec 31, 2023 | $11.5M |
| Eps Diluted | Q1 2025 · Mar 31, 2024 | −$1.11 |
| Eps Basic | Q1 2025 · Mar 31, 2024 | −$1.11 |
| Sga Expense restated | Q1 2025 · Mar 31, 2024 | $2M |
| Rd Expense restated | Q1 2025 · Mar 31, 2024 | $2.19M |
| Net Income | Q1 2025 · Mar 31, 2024 | −$6.6M |
| Operating Income | Q1 2025 · Mar 31, 2024 | −$6.67M |
| Gross Profit | Q1 2025 · Mar 31, 2024 | −$45K |
| Cost Of Revenue | Q1 2025 · Mar 31, 2024 | $109K |